help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thirunavukarasu, P.
Right arrow Articles by Robertson, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thirunavukarasu, P.
Right arrow Articles by Robertson, D. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 12 5794-5804
Copyright © 2001 by The Endocrine Society


Other Original Articles

Changes in Molecular Weight Forms of Inhibin A and Pro-{alpha}C in Maternal Serum during Human Pregnancy

P. Thirunavukarasu, T. Stephenson, J. Forray, P. G. Stanton, N. Groome, E. Wallace and D. M. Robertson

Department of Obstetrics and Gynecology, Monash University (P.T., E.W.), Clayton, 3168 Australia; Oxford Brookes University (N.G.), Oxford OX3 OBP, United Kingdom; and Prince Henry’s Institute of Medical Research (T.S., J.F., P.G.S., D.M.R.), Clayton, Victoria 3168, Australia

Address all correspondence and requests for reprints to: David Robertson, Ph.D., Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia. E-mail: david.robertson{at}med monash.edu.au.

Abstract

Maternal serum pools obtained from healthy women throughout normal pregnancy were fractionated by a combined immunoaffinity chromatography, preparative PAGE, and electroelution procedure. Inhibin A and the pro-{alpha}C region of the inhibin {alpha}-subunit were determined in the eluted fractions by specific ELISAs, and the profiles of immunoactivity characterized in terms of molecular weight and percent recovery. The molecular weight patterns of inhibin A and pro-{alpha}C in serum during early pregnancy (<19 wk gestation) showed peaks between 25–40K and approximately 60K, consistent with the presence of known mature and larger precursor inhibin forms. However, during late pregnancy (>19 wk gestation), an increase in the proportion of smaller molecular weight forms (from 2% to ~25%) of inhibin A and pro-{alpha}C of unknown structure were observed in the less than 30K and less than 25K regions, respectively. To assess whether this change in molecular weight distribution in late pregnancy was related to the method of serum collection, serum and plasma from women during early and late pregnancy were collected and snap-frozen. Three pools [one from early pregnancy (12–15 wk), two from late pregnancy (28–39 wk)] of serum and plasma were then fractionated as described above. No differences in molecular weight patterns of inhibin A and pro-{alpha}C were observed between serum and plasma pools obtained in early pregnancy. However, in late pregnancy there was a reduction in the proportion of low molecular weight forms between serum (25% inhibin A, 35% pro-{alpha}C) and plasma (12% and 17%, respectively), but not to the low levels seen in early pregnancy. Incubation of iodinated 30K human inhibin A with serum or plasma obtained from early or late pregnancy showed no evidence of cleavage, suggesting that 30K inhibin A is not the cleavage precursor. It is speculated that the formation of small molecular weight forms of both inhibin A and pro-{alpha}C is attributed to proteolytic changes, in part induced in the circulation during late gestation and in part by the placenta before secretion. It is concluded that inhibin A and pro-{alpha}C are processed in late pregnancy by more than one mechanism to form low molecular weight circulating forms of unknown structure.




This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Tong, L. Rombauts, J. Onwude, B. Marjono, and E.M. Wallace
Highly specific and sensitive rise in Days 14 17 pro-{alpha}C inhibin with clinical pregnancy after frozen embryo transfer with ovulatory cycles
Hum. Reprod., August 1, 2007; 22(8): 2249 - 2253.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Makanji, C. A. Harrison, P. G. Stanton, R. Krishna, and D. M. Robertson
Inhibin A and B in Vitro Bioactivities Are Modified by Their Degree of Glycosylation and Their Affinities to Betaglycan
Endocrinology, May 1, 2007; 148(5): 2309 - 2316.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Tong, L. Rombauts, A. Mulder, B. Marjono, J. L. Onwude, and E. M. Wallace
Increased Day 15-17 Serum Pro-{alpha}C Inhibin Levels Specific to Successful Pregnancy
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4464 - 4468.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Kaneko, J. Noguchi, K. Kikuchi, and Y. Hasegawa
Molecular Weight Forms of Inhibin A and Inhibin B in the Bovine Testis Change with Age
Biol Reprod, May 1, 2003; 68(5): 1918 - 1925.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society